Wei Wei Prior

2.0k total citations
10 papers, 888 citations indexed

About

Wei Wei Prior is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Wei Wei Prior has authored 10 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Wei Wei Prior's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Wei Wei Prior is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Wei Wei Prior collaborates with scholars based in United States, Netherlands and France. Wei Wei Prior's co-authors include Lori S. Friedman, Deepak Sampath, Jeffrey J. Wallin, Marcia Belvin, Jane Guan, Kyle A. Edgar, Leanne Berry, Leslie B. Lee, Lesley Murray and Suzanne van Dijk and has published in prestigious journals such as The Journal of Cell Biology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Wei Wei Prior

10 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Wei Prior United States	8	644	252	199	147	131	10	888
Eduardo Briceño Chile	7	357 0.6×	399 1.6×	129 0.6×	76 0.5×	109 0.8×	31	736
Pablo Baquero Spain	12	620 1.0×	153 0.6×	188 0.9×	57 0.4×	152 1.2×	17	959
Jiao Ji China	11	618 1.0×	338 1.3×	216 1.1×	103 0.7×	34 0.3×	23	1.0k
Sandaruwan Geeganage United States	11	626 1.0×	74 0.3×	361 1.8×	179 1.2×	120 0.9×	21	1.0k
Daniel Iglesias‐Serret Spain	20	741 1.2×	125 0.5×	306 1.5×	54 0.4×	186 1.4×	32	1.0k
Barry Jutten Netherlands	17	442 0.7×	192 0.8×	209 1.1×	106 0.7×	59 0.5×	19	804
Ana M. Cosialls Spain	18	601 0.9×	85 0.3×	255 1.3×	48 0.3×	178 1.4×	29	842
Olusegun Williams United States	7	996 1.5×	79 0.3×	191 1.0×	78 0.5×	304 2.3×	7	1.3k
Chris J. Novotny United States	9	642 1.0×	74 0.3×	179 0.9×	78 0.5×	66 0.5×	10	829

Countries citing papers authored by Wei Wei Prior

Since Specialization

Citations

This map shows the geographic impact of Wei Wei Prior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wei Prior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wei Prior more than expected).

Fields of papers citing papers by Wei Wei Prior

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wei Prior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wei Prior. The network helps show where Wei Wei Prior may publish in the future.

Co-authorship network of co-authors of Wei Wei Prior

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wei Prior. A scholar is included among the top collaborators of Wei Wei Prior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wei Prior. Wei Wei Prior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Greer, Renee L., Henry T. Nguyen, Ruth Y. Lan, et al.. (2022). 1083 AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that mediates potent anti-tumor activity, cytotoxicity, and expansion of memory CD8+ T cells. Regular and Young Investigator Award Abstracts. A1125–A1125. 2 indexed citations

Wallin, Jeffrey J., Jane Guan, Wei Wei Prior, et al.. (2012). GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In Vivo. Clinical Cancer Research. 18(14). 3901–3911. 73 indexed citations

Salphati, Laurent, Jodie Pang, Emile G. Plise, et al.. (2012). Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human. Drug Metabolism and Disposition. 40(9). 1785–1796. 30 indexed citations

Edgar, Kyle A., Jeffrey J. Wallin, Megan Berry, et al.. (2010). Isoform-Specific Phosphoinositide 3-Kinase Inhibitors Exert Distinct Effects in Solid Tumors. Cancer Research. 70(3). 1164–1172. 94 indexed citations

Bencsik, Josef R., Dengming Xiao, James F. Blake, et al.. (2010). Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(23). 7037–7041. 29 indexed citations

O’Brien, Carol, Jeffrey J. Wallin, Deepak Sampath, et al.. (2010). Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3′ Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models. Clinical Cancer Research. 16(14). 3670–3683. 201 indexed citations

Salphati, Laurent, Harvey Wong, Marcia Belvin, et al.. (2010). Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Inhibition and Biomarker Modulation by the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941. Drug Metabolism and Disposition. 38(9). 1436–1442. 63 indexed citations

Wallin, Jeffrey J., Jane Guan, Wei Wei Prior, et al.. (2010). Nuclear Phospho-Akt Increase Predicts Synergy of PI3K Inhibition and Doxorubicin in Breast and Ovarian Cancer. Science Translational Medicine. 2(48). 48ra66–48ra66. 46 indexed citations

Fields, Carter T., Guangmin Li, Wei Wei Prior, et al.. (2009). Abstract #3239: Enhanced in vitro and in vivo activity of trastuzumab-DM1 antibody-drug conjugate combined with GDC-0941, a small molecule inhibitor of PI3 kinase. Cancer Research. 69. 3239–3239. 3 indexed citations

10.

Degtyarev, Michael, Ann De Mazière, Christine Orr, et al.. (2008). Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. The Journal of Cell Biology. 183(1). 101–116. 347 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact